Amedica Corporation (NASDAQ:AMDA) Files An 8-K Other Events
Item 8.01 Other Events.
On February 27, 2017, Amedica Corporation issued a press release
announcing results of independent femoral head wear testing.A
copy of the press release is attached hereto as Exhibit 99.1 and
is incorporated herein by reference.
Item 9.01 Financial Statements and Exhibits.
| (d) | Exhibits. |
| 99.1 | Amedica Corporation Press Release dated February 27, 2017. |
About Amedica Corporation (NASDAQ:AMDA)
Amedica Corporation is a commercial biomaterial company. The Company is a vertically integrated silicon nitride orthopedic medical device manufacturer. It is focused on using its silicon nitride ceramic technology platform to develop, manufacture and sell a range of medical devices. It is also engaged in developing wear- and corrosion-resistant implant components for hip and knee arthroplasty. The Company markets its Valeo family of silicon nitride interbody spinal fusion devices in the United States, Europe and Brazil for use in the cervical and thoracolumbar areas of the spine. In addition to its silicon nitride-based spinal fusion products, it markets a line of non-silicon nitride spinal surgery products, which allows the Company to provide surgeons and hospitals with a solution for spinal procedures. Its Valeo interbody spinal fusion devices include Anterior Lumbar, Posterior Lumbar, Oblique Lumbar, Transforaminal Lumbar, Lateral Lumbar, Cervical and Corpectomy. Amedica Corporation (NASDAQ:AMDA) Recent Trading Information
Amedica Corporation (NASDAQ:AMDA) closed its last trading session up +0.014 at 0.399 with 163,254 shares trading hands.